Ligand validation:4KRL

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4KRL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4KRL_NAG_A_603	20%	78%	0.231	0.837	0.28	0.6	-	-	1	0	100%	0.9333
4KRL_NAG_A_604	13%	89%	0.303	0.849	0.26	0.39	-	-	0	0	100%	0.9333
3C09_NAG_D_3281	63%	42%	0.161	0.969	0.68	1.54	-	3	4	0	93%	0.9333
4KRM_NAG_G_605	57%	81%	0.135	0.909	0.34	0.48	-	-	0	0	100%	0.9333
3B2U_NAG_E_3371	45%	52%	0.129	0.858	0.55	1.3	-	3	0	0	100%	0.9333
6B3S_NAG_B_602	36%	58%	0.154	0.848	0.52	1.06	-	2	2	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.